Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG–Associated Disease
Despite a low overall disability, every 5th patient with MOGAD experiences cognitive impairment. Cognitive impairment is associated with a higher number of relapses and particularly ADEM/ADEM-like attacks. Although both WM and DGM atrophies are apparent in MOGAD, the latter only seems to have an association with cognitive impairment.
Authors
- Ingo Kleiter (ORCID: https://orcid.org/0000-0002-8249-4408)
- Carsten Lukas (ORCID: https://orcid.org/0000-0002-8562-9697)
- Carolin Schwake (ORCID: https://orcid.org/0000-0003-3669-7244)
- Nadine Siems
- Theodoros Ladopoulos
- Bianca Teegen (ORCID: https://orcid.org/0000-0003-1770-2685)
- Refik Pul (ORCID: https://orcid.org/0000-0002-8940-9317)
- Marius Ringelstein (ORCID: https://orcid.org/0000-0003-3618-8407)
- Iris‐Katharina Penner (ORCID: https://orcid.org/0000-0002-6746-1034)
- Orhan Aktaş (ORCID: https://orcid.org/0000-0002-2020-9210)
- Ruth Schneider (ORCID: https://orcid.org/0000-0002-0997-2725)
- Ann‐Kathrin Kogel (ORCID: https://orcid.org/0000-0002-8217-6063)
- Solveig Lichtenberg
- Ralf Gold (ORCID: https://orcid.org/0000-0002-7223-3052)
- Christian Prehn
- Britta Krieger
- Ilya Ayzenberg (ORCID: https://orcid.org/0009-0007-9491-2180)
Institutions
- Düsseldorf University Hospital (DE)
- Norwegian Womens Public Health Association (NO)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1212/nxi.0000000000200325
- Citations
- 8
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.40